Suppr超能文献

诱导化疗联合放化疗或全喉切除术治疗晚期喉和下咽鳞状细胞癌患者生存情况的配对分析

Matched-Pair Analysis of Survival in the Patients with Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Treated with Induction Chemotherapy Plus Chemo-Radiation or Total Laryngectomy.

作者信息

García-Cabo Patricia, López Fernando, Sánchez-Canteli Mario, Fernández-Vañes Laura, Álvarez-Marcos César, Llorente José Luis, Rúa Maria Ángeles de la, Blay Pilar, Rodrigo Juan P

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, IUOPA, CIBERONC-ISCIII, 33011 Oviedo, Spain.

出版信息

Cancers (Basel). 2021 Apr 6;13(7):1735. doi: 10.3390/cancers13071735.

Abstract

We performed a comparative analysis between an organ-preservation protocol and surgery followed by radiotherapy in patients with locally advanced squamous cell carcinoma of the larynx and hypopharynx; Methods: 60 previously untreated patients who were treated with induction chemotherapy followed by chemoradiotherapy in responders were compared with a control group of 60 patients treated with up-front surgery. Both groups were statistically comparable, according to the subsite, TNM (tumor-node-metastasis) stage, age, and sex; Results: Mean age was 58 years and 92% were male. No significant statistical difference was observed for overall survival (OS) (HR 0.75; 95% CI 0.48-1.18; = 0.22) and disease-specific survival (DSS) (HR 0.98; 95% CI 0.52-1.83, = 0.96). Also, there was no significant difference for recurrence-free survival (HR 0.931; 95% CI 0.57-1.71; = 0.81), metastases-free survival (HR 2.23; 95% CI 0.67-7.41; = 0.19), and the appearance of second primary tumors (HR 1.22; 95% CI 0.51-2.88; = 0.64); Conclusions: The results of the organ-preservation approach did not appear inferior to those of surgery plus (chemo)radiotherapy for patients with T3/T4a larynx and T2-T4a hypopharynx cancer with respect to OS and DSS, locoregional control and metastases-free survival.

摘要

我们对局部晚期喉和下咽鳞状细胞癌患者采用器官保留方案与手术加放疗进行了对比分析;方法:将60例接受诱导化疗后对反应者进行放化疗的初治患者与60例接受 upfront 手术的对照组患者进行比较。根据亚部位、TNM(肿瘤-淋巴结-转移)分期、年龄和性别,两组在统计学上具有可比性;结果:平均年龄为58岁,92%为男性。总生存期(OS)(风险比0.75;95%置信区间0.48 - 1.18;P = 0.22)和疾病特异性生存期(DSS)(风险比0.98;95%置信区间0.52 - 1.83,P = 0.96)未观察到显著统计学差异。此外,无复发生存期(风险比0.931;95%置信区间0.57 - 1.71;P = 0.81)、无转移生存期(风险比2.23;95%置信区间0.67 - 7.41;P = 0.19)和第二原发肿瘤的出现(风险比1.22;95%置信区间0.51 - 2.88;P = 0.64)也无显著差异;结论:对于T3/T4a期喉癌和T2 - T4a期下咽癌患者,在总生存期、疾病特异性生存期、局部区域控制和无转移生存期方面,器官保留方法的结果似乎并不逊于手术加(化疗)放疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4abb/8038732/3ad3a010a2bf/cancers-13-01735-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验